NCT02232087View on ClinicalTrials.gov

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

Salmeterol

A, D 2 puffs; B, E 6 puffs; C, F 12 puffs

DRUG

fluticasone propionate

A, D 2 puffs; B, E 6 puffs; C, F 12 puffs

Trial Locations (1)

NG11 6JS

Quotient Clinical Ltd, Ruddington

Sponsors
All Listed Sponsors
lead

Kindeva Drug Delivery

INDUSTRY